Figure 1From: The prognostic value of expression of HIF1α, EGFR and VEGF-A, in localized prostate cancer for intermediate- and high-risk patients treated with radiation therapy with or without androgen deprivation therapy Biological progression-free survival as a function of HIF1α (A), EGFR (B) and VEGF-A (C) expression in 103 intermediate- and high-risk prostate cancer. Back to article page